HomeHealthEli Lilly seeks FDA approval for weight loss drug tirzepatide

Eli Lilly seeks FDA approval for weight loss drug tirzepatide

Published on

spot_img

Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News

Watch CBS News


Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


Source link

Latest articles

Microsoft pens AI cloud computing deal with former Ethereum miner CoreWeave: CNBC

Microsoft has reportedly signed a deal with former Ethereum miner CoreWeave to use its...

Djokovic irked by booing during French Open win

PARIS -- Novak Djokovic makes no secret of the way he loves to...

Churchill Downs slate relocated after 12 deaths

Katherine Terrell, ESPN Staff WriterJun 2, 2023, 05:39 PM ETCloseCovered the NFL since...

LSU among Day 1 winners at baseball regionals

The first day of the NCAA baseball tournament headed into Friday night with...

More like this

Microsoft pens AI cloud computing deal with former Ethereum miner CoreWeave: CNBC

Microsoft has reportedly signed a deal with former Ethereum miner CoreWeave to use its...

Djokovic irked by booing during French Open win

PARIS -- Novak Djokovic makes no secret of the way he loves to...

Churchill Downs slate relocated after 12 deaths

Katherine Terrell, ESPN Staff WriterJun 2, 2023, 05:39 PM ETCloseCovered the NFL since...